These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3142825)

  • 1. Treatment protocols: practical considerations for hospital implementation of thrombolytic therapy with tissue plasminogen activator.
    Greco A
    Heart Lung; 1988 Nov; 17(6 Pt 2):787-92. PubMed ID: 3142825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolytic therapy: a case study.
    Moseley MJ
    Crit Care Nurse; 1992 Mar; 12(3):62-8. PubMed ID: 1559384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the nurse in thrombolytic therapy.
    Albarran J; Kapeluch H
    Br J Nurs; 1994 Feb 10-23; 3(3):104-9. PubMed ID: 8148624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What you should know about thrombolytic therapy for acute MI.
    Aragon D; Martin M
    Am J Nurs; 1993 Sep; 93(9):24-31; quiz 33. PubMed ID: 8213959
    [No Abstract]   [Full Text] [Related]  

  • 5. Contemporary challenges in the management of acute myocardial infarction: ST-elevation myocardial infarction guidelines and the real world.
    Henry T
    Am Heart J; 2006 Jun; 151(6 Suppl):S11-6. PubMed ID: 16777504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of acute myocardial infarction guidelines in community hospitals.
    Larson DM; Sharkey SW; Unger BT; Henry TD
    Acad Emerg Med; 2005 Jun; 12(6):522-7. PubMed ID: 15930403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improve AMI (acute myocardial infarction) therapy by working with ICU, ED.
    Hosp Case Manag; 1996 Nov; 4(11):172-5. PubMed ID: 10172888
    [No Abstract]   [Full Text] [Related]  

  • 8. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of intravenous thrombolysis prior to percutaneous coronary intervention in reperfusion therapy for acute myocardial infarction].
    Uto K; Ota Y; Mizuno M; Nakamura A; Nakajima R; Endoh Y; Kasanuki H
    J Cardiol; 2002 Dec; 40(6):241-8. PubMed ID: 12528645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing the time to thrombolysis in acute myocardial infarction. Time to Thrombolysis Substudy of the National Registry of Myocardial Infarction-1.
    Lambrew CT; Bowlby LJ; Rogers WJ; Chandra NC; Weaver WD
    Arch Intern Med; 1997 Dec 8-22; 157(22):2577-82. PubMed ID: 9531226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolytic therapy for acute myocardial infarction. Are inclusion criteria too stringent?
    Handlin LR; Vacek JL
    Postgrad Med; 1994 Mar; 95(4):77-82. PubMed ID: 8121861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic agents in critical care.
    Weiner B
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):355-66. PubMed ID: 8398041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ST-segment-elevation myocardial infarction: guidelines and the challenge of real-world patient care.
    Spinler SA
    Pharmacotherapy; 2006 Aug; 26(8 Pt 2):115S-122S. PubMed ID: 16863477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addendum: a standardized nursing care plan for the acute myocardial infarction patient receiving tissue-type plasminogen activator.
    Erickson DE; Kleven M
    Heart Lung; 1987 Nov; 16(6 Pt 2):794-800. PubMed ID: 3119524
    [No Abstract]   [Full Text] [Related]  

  • 15. Action by physicians and other health-care professionals in hospital emergency departments.
    Doty WD; Curry CR; Goellner W; Holman KI; Rodenburg H; Rogers EW; Wasserman F
    J Fla Med Assoc; 1995 Feb; 82(2):108-42. PubMed ID: 7707035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
    Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
    Arch Intern Med; 1994 Oct; 154(19):2237-42. PubMed ID: 7944845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombolysis in acute myocardial infarct. Initial experiences in a Swiss university hospital].
    Ritz R; Schoenenberger R; Burckhardt D; Burkart F; Pfisterer M; Ritschard T; Weiss P
    Schweiz Med Wochenschr; 1988 Nov; 118(46):1706-10. PubMed ID: 3145557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators.
    Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe JH; Hartzler GO; Overlie P; Donohue B; Chelliah N; Vlietstra R; Puchrowicz-Ochocki S; O'Neill WW
    Cathet Cardiovasc Diagn; 1996 Dec; 39(4):333-9. PubMed ID: 8958418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prehospital thrombolytic therapy of acute myocardial infarct].
    Tebbe U; Carlsson J
    Herz; 1994 Dec; 19(6):303-13. PubMed ID: 7843687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
    Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
    Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.